» Articles » PMID: 35562754

5-methylcytosine RNA Methyltransferases and Their Potential Roles in Cancer

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2022 May 13
PMID 35562754
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, 5-methylcytosine (mC) RNA modification has emerged as a key player in regulating RNA metabolism and function through coding as well as non-coding RNAs. Accumulating evidence has shown that mC modulates the stability, translation, transcription, nuclear export, and cleavage of RNAs to mediate cell proliferation, differentiation, apoptosis, stress responses, and other biological functions. In humans, mC RNA modification is catalyzed by the NOL1/NOP2/sun (NSUN) family and DNA methyltransferase 2 (DNMT2). These RNA modifiers regulate the expression of multiple oncogenes such as fizzy-related-1, forkhead box protein C2, Grb associated-binding protein 2, and TEA domain transcription factor 1, facilitating the pathogenesis and progression of cancers. Furthermore, the aberrant expression of methyltransferases have been identified in various cancers and used to predict the prognosis of patients. In this review, we present a comprehensive overview of mC RNA methyltransferases. We specifically highlight the potential mechanism of action of mC in cancer. Finally, we discuss the prospect of mC-relative studies.

Citing Articles

Causal relationships of gut microbiota and blood metabolites with ovarian cancer and endometrial cancer: a Mendelian randomization study.

Chen J, Chen X, Ma J J Ovarian Res. 2025; 18(1):54.

PMID: 40082983 PMC: 11905533. DOI: 10.1186/s13048-025-01630-5.


Detection, molecular function and mechanisms of m5C in cancer.

Zhang L, Li Y, Li L, Yao F, Cai M, Ye D Clin Transl Med. 2025; 15(3):e70239.

PMID: 40008496 PMC: 11862898. DOI: 10.1002/ctm2.70239.


Biological functions of 5-methylcytosine RNA-binding proteins and their potential mechanisms in human cancers.

Zhao T, Zhang Z, Chen Z, Xu G, Wang Y, Wang F Front Oncol. 2025; 15:1534948.

PMID: 39990690 PMC: 11842269. DOI: 10.3389/fonc.2025.1534948.


Current status and new directions for hepatocellular carcinoma diagnosis.

Tu J, Wang B, Wang X, Huo K, Hu W, Zhang R Liver Res. 2025; 8(4):218-236.

PMID: 39958920 PMC: 11771281. DOI: 10.1016/j.livres.2024.12.001.


RNA modifications in cancer.

Wu H, Chen S, Li X, Li Y, Shi H, Qing Y MedComm (2020). 2025; 6(1):e70042.

PMID: 39802639 PMC: 11718328. DOI: 10.1002/mco2.70042.


References
1.
Van Haute L, Lee S, McCann B, Powell C, Bansal D, Vasiliauskaite L . NSUN2 introduces 5-methylcytosines in mammalian mitochondrial tRNAs. Nucleic Acids Res. 2019; 47(16):8720-8733. PMC: 6822013. DOI: 10.1093/nar/gkz559. View

2.
He M, Fan J, Jiang R, Tang W, Wang Z . Expression of DNMTs and MBD2 in GIST. Biomed Rep. 2014; 1(2):223-227. PMC: 3956211. DOI: 10.3892/br.2012.34. View

3.
Chen X, Li A, Sun B, Yang Y, Han Y, Yuan X . 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell Biol. 2019; 21(8):978-990. DOI: 10.1038/s41556-019-0361-y. View

4.
Sun F, Wu K, Yao Z, Mu X, Zheng Z, Sun M . Long Noncoding RNA PVT1 Promotes Prostate Cancer Metastasis by Increasing NOP2 Expression via Targeting Tumor Suppressor MicroRNAs. Onco Targets Ther. 2020; 13:6755-6765. PMC: 7360424. DOI: 10.2147/OTT.S242441. View

5.
Mortazavi F, An J, Dubinett S, Rettig M . p120-catenin is transcriptionally downregulated by FOXC2 in non-small cell lung cancer cells. Mol Cancer Res. 2010; 8(5):762-74. DOI: 10.1158/1541-7786.MCR-10-0004. View